Foghorn Therapeutics Inc. Assets, Fair Value Disclosure
Foghorn Therapeutics Inc. (FHTX) had Assets, Fair Value Disclosure of $167.42 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-06
- 2026-06-30: Assets, Fair Value Disclosure $167.42M.
- 2026-03-31: Assets, Fair Value Disclosure $183.43M.
- 2025-12-31: Assets, Fair Value Disclosure $158.60M.
- 2024-12-31: Assets, Fair Value Disclosure $233.57M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $167.42M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $183.43M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $158.60M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $233.57M 10-K · filed 2026-03-11 |
| 2020-12-31 | $184.74M 10-K/A · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |